A trial evaluating the effectiveness of combining standard R-CHOP treatment with acalabrutinib in patients with newly diagnosed diffuse large B-cell lymphoma

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2021
This article has no abstract
Epistemonikos ID: ebc045b1b862cc9212b083de07264553f114ee73
First added on: Jan 17, 2025